FBXW7 and Cognitive impairment: Two studies reported the positive effects of AGO on diabetic encephalopathy or cognitive impairment (2/2, 100%) and demonstrated that treatment effectively reversed the impaired learning, memory performance, and emotional learning of diabetic rats with comparable efficacy to piracetam [35].